Sakar Healthcare Limited SHARE PRICE [LIVE]
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Dec 22 | Sep 22 |
|---|---|---|
| Promoters (Change:0.00) | 62.1% | 62.1% |
| FIIs (Change:0.00) | 16.12% | 16.12% |
| Mutual Funds (Change:0.00) | 0% | 0% |
| Insurance Companies (Change:0.00) | 0% | 0% |
| Other DIIs (Change:-0.22) | 0.33% | 0.55% |
| Non Institution (Change:0.21) | 21.45% | 21.24% |
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in Sakar Healthcare Limited
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
SAKAR News
Frequently Asked Questions
What is the Share price of Sakar Healthcare Limited (SAKAR)?
Can I buy Sakar Healthcare Limited (SAKAR) shares?
How do I buy Sakar Healthcare Limited (SAKAR) from Angel One?
- Direct investment: You can buy Sakar Healthcare Limited (SAKAR) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Sakar Healthcare Limited (SAKAR) shares.
About SAKAR
Today's live share price for Sakar Healthcare Limited is NSE: ₹ 237.45, BSE: N/A with a current market capitalization of .
Sakar Healthcare Limited was incorporated as a private limited company under the name "Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the company was converted into public limited company on March 27, 2015 and the name of the company was changed to "Sakar Healthcare Limited. The company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The company is in the business of contract manufacturing of formulation for pharmaceutical companies based in India further it also undertake in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. The company manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc
Read more
